INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 257 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $325,188 | -9.1% | 8,515 | -2.1% | 0.00% | -20.0% |
| Q2 2023 | $357,625 | -35.1% | 8,695 | -9.4% | 0.01% | -37.5% |
| Q1 2023 | $551,079 | +2.0% | 9,599 | -0.3% | 0.01% | -11.1% |
| Q4 2022 | $540,010 | +48.8% | 9,631 | +12.4% | 0.01% | +28.6% |
| Q3 2022 | $363,000 | -21.1% | 8,568 | +0.7% | 0.01% | -22.2% |
| Q2 2022 | $460,000 | -10.2% | 8,509 | +6.9% | 0.01% | 0.0% |
| Q1 2022 | $512,000 | -6.2% | 7,961 | -2.3% | 0.01% | 0.0% |
| Q4 2021 | $546,000 | -2.0% | 8,145 | +0.0% | 0.01% | -18.2% |
| Q3 2021 | $557,000 | -1.9% | 8,141 | -2.1% | 0.01% | +10.0% |
| Q2 2021 | $568,000 | +10.5% | 8,319 | +11.8% | 0.01% | -9.1% |
| Q1 2021 | $514,000 | +7.1% | 7,444 | +0.8% | 0.01% | +10.0% |
| Q4 2020 | $480,000 | +36.8% | 7,387 | -0.7% | 0.01% | +11.1% |
| Q3 2020 | $351,000 | +17.4% | 7,438 | +16.8% | 0.01% | +12.5% |
| Q2 2020 | $299,000 | – | 6,369 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VeriStar Capital Management LP | 268,000 | $10,234,920 | 8.72% |
| Madison Avenue Partners, LP | 964,667 | $36,840,633 | 5.23% |
| Pavadi Capital LLC | 99,999 | $3,818,962 | 4.97% |
| KESTREL INVESTMENT MANAGEMENT CORP | 122,450 | $4,676 | 2.96% |
| Sapience Investments, LLC | 245,700 | $9,383,283 | 2.26% |
| Ellsworth Advisors, LLC | 102,500 | $3,882,700 | 1.38% |
| Point72 Europe (London) LLP | 464,462 | $17,737,804 | 1.09% |
| COOKE & BIELER LP | 2,714,194 | $103,655,069 | 1.01% |
| TANDEM CAPITAL MANAGEMENT CORP /ADV | 75,586 | $2,886,630 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,827 | $43,033,523 | 0.95% |